RSI News
As necessary and sparingly, RSI publishes short news items that demonstrate the range of work in which our team is engaged. Only when relevant and permissible do we mention the actual client, otherwise we simply refer to the type of client.
Dr. Donald Mattison, RSI’s Senior Vice-President and Chief Medical Officer, has accepted an appointment as a University of South Carolina Health Sciences Distinguished Professor in the in the Arnold School of Public Health (ASPH). The appointment noted that Dr. Mattison’s broad and deep career experience as a researcher and educator is impressive and…
RSI is pleased to be the recipient of funding through the DND IDEaS COVID-19 Challenge. Under the supervision of Emma Hartnett, RSI will be developing a risk-based tool to support public health emergency response planning for COVID-19, and other infectious disease and mass casualty emergencies in the future. The safety…
Calvin C. Willhite, an Associate Expert with Risk Sciences International working on a range of toxicological risk issues, was just announced as the recipient of the prestigious 2021 Arnold Lehman Award presented annually by the Society of Toxicology for outstanding contributions to evidence-based toxicology to improve public health. Dr. Willhite specializes in human…
RSI experts Jennifer Go and Daniel Krewski, were recently invited to present a paper on maternal and child environmental heath during a global, virtual workshop originating in Foshan, Guangdong, China.
Risk Sciences International will host Abdallah Alami as an intern in statistics with support from the Mitacs Accelerate program. This unique university-industry program supports interns at Canadian companies while completing graduate their training at Canadian universities. Mr. Alami will be completing his MSc in statistics at Carleton University under the supervision…
Compounded medications prepared by pharmacists or physicians have been used extensively throughout history as a mainstay of therapeutics. Over the past half-century – with the increasing focus on evidence based treatment the use of compounded medications substantially decreased. However, in some therapeutic areas, such as menopause, use of compounded medications…
Leading up to February 11 and 12, 2020, Risk Sciences International had the privilege of assisting Health Canada in its organization of the Country Foods Forum. The event attracted a number of experts in country foods risk assessment from across Canada. Participants and speakers represented a broad cross section of…
Risk Sciences International is organizing a two day Workshop on Evidence Integration in support of human health risk assessment in collaboration with the McLaughlin Centre for Population Health Risk Assessment at the University of Ottawa and the Center for Alternatives to Animal Testing at Johns Hopkins University. The meeting will…
Risk Sciences International (RSI), as members of a consulting team with Stantec, along with the Ontario First Nations Technical Services Corporation (OFNTSC), has won an Award of Merit from the Consulting Engineers of Ontario for the First Nations Infrastructure Resilience Toolkit (FN-IRT). The Consulting Engineers of Ontario Awards showcases projects that enrich society through application…